Perspective Therapeutics (CATX) Other Operating Expenses (2010 - 2024)
Perspective Therapeutics (CATX) reported Other Operating Expenses of -$27000.0 for Q4 2024, down 222.73% on a YoY basis from $22000.0 in Q1 2024, and up 55.74% sequentially from -$61000.0 in Q2 2024.
Perspective Therapeutics (CATX) Other Operating Expenses (2010 - 2024) Analysis & Trends
Perspective Therapeutics (CATX) has 15 years of Other Operating Expenses data on file, last reported at -$27000.0 in Q4 2024.
- For the quarter ending Q4 2024, Other Operating Expenses fell 222.73% year-over-year to -$27000.0; the trailing twelve-month figure through Sep 2025 stood at -$27000.0 (up 30.77% YoY), and the FY2024 full-year result was -$27000.0, changed N/A from the prior year.
- Other Operating Expenses grew to -$27000.0 in Q4 2024, from -$61000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $805000.0 in Q1 2020 to a low of -$1.2 million in Q2 2020.
- A 5-year average of $44583.3 and a median of -$4500.0 in 2020 frame the typical range for Other Operating Expenses.
- Across the five-year window, Other Operating Expenses soared 80400.0% in 2020 and slumped 222.73% in 2024, its largest moves.
- Tracing CATX's Other Operating Expenses over 5 years: stood at -$7000.0 in 2020, then surged by 10128.57% to $702000.0 in 2021, then plunged by 143.45% to -$305000.0 in 2022, then surged by 107.21% to $22000.0 in 2023, then tumbled by 222.73% to -$27000.0 in 2024.
- Business Quant data shows CATX's Other Operating Expenses at -$27000.0 in Q4 2024, -$61000.0 in Q2 2024, and $22000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Perspective Therapeutics | 146.05 Mn | 146.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -27,000.00 |
| Jun 30, 2024 | -61,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Mar 31, 2023 | -22,000.00 |
| Dec 31, 2022 | -305,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Sep 30, 2021 | 702,000.00 |
| Mar 31, 2021 | -2,000.00 |
| Dec 31, 2020 | -7,000.00 |
| Sep 30, 2020 | 581,000.00 |
| Jun 30, 2020 | -1.16 Mn |
| Mar 31, 2020 | 805,000.00 |
| Dec 31, 2019 | 277,000.00 |
| Sep 30, 2019 | 742,000.00 |
| Mar 31, 2019 | 1,000.00 |
| Dec 31, 2018 | 23,000.00 |
| Sep 30, 2018 | 649,000.00 |
| Jun 30, 2018 | 572,000.00 |
| Mar 31, 2018 | 692,000.00 |
| Dec 31, 2017 | 674,000.00 |